Mark Currie

Mark Currie

Directeur/Membre du Conseil chez IRONWOOD PHARMACEUTICALS, INC.

Fortune : 2 M $ au 31/05/2026

71 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mark G.
Currie
currently works at Science Exchange, Inc., as Director from 2020, Antag Therapeutics ApS, as Director, Sea Pharmaceuticals LLC, as Director from 2021, Ironwood Pharmaceuticals, Inc., as Independent Director from 2019, and Iaso Ventures LP, as Partner.
Dr. Currie also formerly worked at Monsanto Co., as Director-Arthritis & Inflammation, G.D.
Searle & Co., Inc., as Director-Arthritis & Inflammation, Sumitomo Pharma America, Inc., as Vice President-Discovery Research from 1999 to 2002, Ironwood Pharmaceuticals, Inc., as Chief Scientific Officer, President-R&D, Senior VP from 2002 to 2019, and Cyclerion Therapeutics, Inc., as President & Chief Scientific Officer from 2019 to 2020.
Dr. Currie received his doctorate degree from Wake Forest School of Medicine and undergraduate degree from the University of South Alabama.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/06/2026 676 900 ( 0,41% ) 2 M $ 31/05/2026

Postes actifs de Mark Currie

SociétésPosteDébut
IRONWOOD PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2019
Directeur/Membre du Conseil 12/02/2020
Directeur/Membre du Conseil 01/02/2021
Directeur/Membre du Conseil -
Corporate Officer/Principal -

Anciens postes connus de Mark Currie

SociétésPosteFin
CYCLERION THERAPEUTICS, INC. President 01/12/2020
IRONWOOD PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 01/03/2019
Corporate Officer/Principal 01/08/2002
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Mark Currie

Formation de Mark Currie

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

50

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Commercial Services

Consumer Services

Health Technology

Process Industries

Consumer Services

Technology Services

Commercial Services

Health Services

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Mark Currie